PT Royalindo Investa Wijaya Tbk (IDX:INDO)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	860,302	508,799	390,073	396,556	440,273	542,954
Market Cap Growth	46.34%	30.44%	-1.64%	-9.93%	-18.91%	-
Enterprise Value	568,497	228,032	93,331	47,441	-176,855	-247,323
Last Close Price	192.00	116.00	89.00	91.00	102.00	126.00
PE Ratio	40.18	23.69	31.59	12.31	51.20	11.40
PS Ratio	29.96	18.89	22.21	38.54	58.59	176.04
PB Ratio	0.80	0.49	0.39	0.41	0.45	0.56
P/OCF Ratio	33.26	18.21	17.32	24.29	222.37	-
EV/Sales Ratio	19.80	8.47	5.32	4.61	-	-
EV/EBITDA Ratio	21.09	19.56	19.13	19.88	-	-
EV/EBIT Ratio	24.59	26.34	28.40	37.55	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.07	0.07	0.26	0.21	0.77	0.03
Asset Turnover	0.03	0.03	0.02	0.01	0.01	0.00
Quick Ratio	70.23	98.15	74.18	200.31	297.35	484.37
Current Ratio	74.86	102.87	78.46	212.18	316.88	504.04
Return on Equity (ROE)	2.28%	2.06%	1.25%	3.29%	0.88%	5.32%
Return on Assets (ROA)	0.55%	0.53%	0.21%	0.08%	0.05%	3.13%
Return on Capital (ROIC)	0.55%	0.53%	0.21%	0.08%	0.05%	3.35%
Earnings Yield	2.89%	4.22%	3.17%	8.13%	1.95%	8.77%
Buyback Yield / Dilution	-18.17%	-17.81%	-0.62%	-1.00%	-0.08%	-149938.30%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.